Cases 51 - 60 of 871
MAGO v. MYLAN LABORATORIES LTD. et al
as 1:2022cv07601
Plaintiff:
JHEINGEL MAGO
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In re: Fosamax (Alendronate Sodium) Products Liabi
as 22-3412
Plaintiff / Appellant:
PHYLLIS MOLNAR, and all other plaintiffs listed in Exhibit A to notice of appeal
Defendant / Appellee:
MERCK & CO INC, MERCK SHARP & DOHME CORP, SUN PHARMA GLOBAL and others
VICTORIA SPATARO et al v. VALUE DRUG COMPANY
as 2:2022cv06910
Petitioner:
VICTORIA SPATARO, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD. and others
Respondent:
VALUE DRUG COMPANY
Interested Party:
TAKEDA PHARMACEUTICALS U.S.A., INC., PAR PHARMACEUTICAL INC. and AMNEAL PHARMACEUTICALS LLC
VICTORIA SPATARO et al v. VALUE DRUG COMPANY
as 3:2022cv06910
Petitioner:
VICTORIA SPATARO, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD. and others
Respondent:
VALUE DRUG COMPANY
Interested Party:
TAKEDA PHARMACEUTICALS U.S.A., INC., PAR PHARMACEUTICAL INC. and AMNEAL PHARMACEUTICALS LLC
Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv01461
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al
as 1:2022cv01462
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06466
Plaintiff:
DERWIN BAKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ENANDER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv06383
Plaintiff:
MARK ENANDER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TSAKALAS v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06294
Plaintiff:
DEBORAH TSAKALAS
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
